SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-147133
Filing Date
2016-10-27
Accepted
2016-10-27 16:10:53
Documents
2
Period of Report
2016-10-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 18056
2 POA DOCUMENT poa.txt EX-24.3_681105 4158
  Complete submission text file 0001209191-16-147133.txt   23644
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERULEAN PHARMA INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Eliasof Scott (Reporting) CIK: 0001688065 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 161955637